NeurogesX, Inc. (NGSX) – Analyst Ratings
-
Wedbush Upgrades NeurogesX, Inc. (NGSX) to Outperform; Restructuring Puts NGX-1998 Liquid Formulation On Center Stage
-
NeurogesX (NGSX) Sees Upside Despite Unlikely FDA Approval
-
-
-
-
-
-
-
Back to NGSX Stock Lookup